IRIX
Price
$0.76
Change
-$0.01 (-1.30%)
Updated
Oct 22 closing price
Capitalization
13.39M
19 days until earnings call
Intraday BUY SELL Signals
NEO
Price
$16.39
Change
-$0.65 (-3.81%)
Updated
Oct 22 closing price
Capitalization
2.11B
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRIX vs NEO

IRIX vs NEO Comparison Chart in %
View a ticker or compare two or three
VS
IRIX vs. NEO commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRIX is a Hold and NEO is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IRIX with price predictions
Oct 22, 2026

IRIX sees MACD Histogram just turned negative

IRIX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 21, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 39 instances where the indicator turned negative. In 35 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IRIX moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IRIX as a result. In 85 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

IRIX broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

IRIX moved above its 50-day moving average on October 07, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IRIX crossed bullishly above the 50-day moving average on October 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.

Following a +32.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRIX advanced for three days, in 153 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

The Aroon Indicator entered an Uptrend today. In 81 of 112 cases where IRIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. IRIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-5.671) is normal, around the industry mean (2.874). P/E Ratio (-3.812) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (3.870) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.204) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for NEO with price predictions
Oct 22, 2026

Aroon Indicator for NEO shows an upward move is likely

NEO's Aroon Indicator triggered a bullish signal on September 30, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 189 similar instances where the Aroon Indicator showed a similar pattern. In 155 of the 189 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 59 cases where NEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NEO as a result. In 65 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

Following a +3.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 215 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

NEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for NEO moved out of overbought territory on September 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Moving Average Convergence Divergence Histogram (MACD) for NEO turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 37 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

NEO moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NEO crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.680) is normal, around the industry mean (66.046). P/E Ratio (-42.026) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

FUNDAMENTALS RATINGS
IRIX vs NEO: Fundamental Ratings
IRIX
NEO
OUTLOOK RATING
1..100
9711
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
5937
P/E GROWTH RATING
1..100
2359
SEASONALITY SCORE
1..100
9041

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (27) in the Medical Or Nursing Services industry is somewhat better than the same rating for IRIX (78) in the Medical Specialties industry. This means that NEO’s stock grew somewhat faster than IRIX’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as IRIX (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to IRIX’s over the last 12 months.

NEO's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as IRIX (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to IRIX’s over the last 12 months.

NEO's Price Growth Rating (37) in the Medical Or Nursing Services industry is in the same range as IRIX (59) in the Medical Specialties industry. This means that NEO’s stock grew similarly to IRIX’s over the last 12 months.

IRIX's P/E Growth Rating (23) in the Medical Specialties industry is somewhat better than the same rating for NEO (59) in the Medical Or Nursing Services industry. This means that IRIX’s stock grew somewhat faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRIXNEO
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 15 days ago
75%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (IRIX: $0.77 vs. NEO: $16.39)
Brand notoriety: IRIX and NEO are both not notable
IRIX represents the Medical/Nursing Services, while NEO is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRIX: 7% vs. NEO: 73%
Market capitalization -- IRIX: $13.39M vs. NEO: $2.11B
IRIX [@Medical/Nursing Services] is valued at $13.39M. NEO’s [@Medical Specialties] market capitalization is $2.11B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Medical Specialties] industry is $21.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRIX’s FA Score shows that 1 FA rating(s) are green while NEO’s FA Score has 1 green FA rating(s).

  • IRIX’s FA Score: 1 green, 4 red.
  • NEO’s FA Score: 1 green, 4 red.
According to our system of comparison, NEO is a better buy in the long-term than IRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRIX’s TA Score shows that 5 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • IRIX’s TA Score: 5 bullish, 5 bearish.
  • NEO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IRIX and NEO are a good buy in the short-term.

Price Growth

IRIX (@Medical/Nursing Services) experienced а -6.84% price change this week, while NEO (@Medical Specialties) price change was -4.99% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.29%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +42.53%.

Reported Earning Dates

IRIX is expected to report earnings on Nov 10, 2026.

NEO is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-3.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
IRIX
Daily Signal:
Gain/Loss:
NEO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

IRIX and

Correlation & Price change

A.I.dvisor tells us that IRIX and NTRA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRIX and NTRA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRIX
1D Price
Change %
IRIX100%
-0.70%
NTRA - IRIX
30%
Poorly correlated
-2.91%
NEO - IRIX
27%
Poorly correlated
-3.81%
IQV - IRIX
27%
Poorly correlated
+0.61%
MDXH - IRIX
26%
Poorly correlated
-14.34%
DRIO - IRIX
26%
Poorly correlated
-5.98%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RJVI24.550.20
+0.83%
RJ Eagle Vertical Income ETF (RJVI)
VALG13.49N/A
N/A
Leverage Shares 2X Long VALE Daily ETF (VALG)
ITDB34.89-0.06
-0.18%
iShares LifePath Target Date 2030 ETF (ITDB)
AAAA30.16-0.31
-1.02%
Amplius Aggressive Asset Allocation ETF (AAAA)
TGRW46.02-1.44
-3.03%
T. Rowe Price Growth Stock ETF (TGRW)